Background: At therapeutic concentrations, the antineoplastic agent taxol selectively perturbs mitotic spindle microtubules. Taxol has recently been shown to induce apoptosis, similar to the mechanism of cell death induced by other antineoplastic agents. However, taxol has shown efficacy against drug-refractory cancers, raising the possibility that this pharmacological agent may trigger an alternative apoptotic pathway. Materials and Methods: The kinetics and IC50 of mitotic (M) block, aberrant mitosis, and cytotoxicity following taxol treatment were analyzed in human cell lines as well as normal mouse embryo fibroblasts (MEFs) and MEFs derived from p53-null mice. Apoptosis was followed by DNA gel electrophoresis and by in situ DNA end-labeling (TUNEL). Results: Taxol induced two forms of cell cycle arrest: either directly in early M at prophase or, for those cells progressing through aberrant mitosis, arrest in G1 as
INTRODUCTION
Taxol is a complex plant alkaloid with a unique taxane ring structure which appears to target microtubules (MTs) specifically both in vitro and in vivo (1) (2) (3) (4) (5) (6) . Taxol binds to the polymeric microtubule form of tubulin in a 1:1 stoichiometry with a13-tubulin heterodimer subunits (2, 4, 7) . Binding markedly shifts the dynamic instability equilibrium of MT polymers, stabilizing against dissociation and hence augmenting polymerization. Bound taxol overrides the need for GTP hydrolysis in tubulin heterodimer polymeriza-structural filaments in the eukaryotic cell and play a key role in a wide repertoire of cellular processes: endocytosis, vesicular movement, cell morphology and motility, and mitosis to name but a few (17) . Somewhat surprisingly, however, taxol concentrations within the therapeutic range are not necessarily sufficient to cause gross rearrangements of interphase MT arrays and leave a functional MT scaffold intact. Therefore, it is not immediately apparent why taxol should be cytotoxic rather than merely cytostatic. In cultured human cell lines, taxol has been shown to induce a block in the cell cycle at the G2/M transition ( 1, (18) (19) (20) (21) (22) (23) . At the G2/M transition, cellular MTs undergo a dramatic reorganization associated with a sudden change in the centrosomal MT-nucleating activity (5, 6, 23, 24) . Interphase MTs dissociate (even in the presence of taxol) as the centrosomes concurrently elaborate the mitotic spindle MTs (5, 6, 23, 24) . Interestingly, this sudden change in centrosomal activity correlates with association of p34Cdc2/cyclin B complex with the centrosome (23, 25) . Taxol induces aberrant multipolar spindle formation that causes mitotic arrest (5, 6, 26) . Recent studies with human lines have provided strong evidence that it is this arrest in M that correlates with cytotoxicity (18, (20) (21) (22) 27, 28) . For HeLa cells, the EC50 for arrest at the G2/M transition is similar for the EC50 for taxol-induced cytotoxicity and 1 to 2 orders of magnitude lower than the doses required to induce gross changes in interphase MT arrays (18) . Rodent cells are also sensitive to taxol in ranges that perturb mitosis but appear to be more tolerant of arrest in mitosis; they eventually assume a multimininucleated phenotype resulting from aberrant mitosis and lack of cytokinesis. Doses effecting these changes are also cytotoxic (5, 6, 19) . Species differences between human and rodent lines have been attributed to differences in p34cdc2 regulation (19) .
Taken together, these studies predict that taxol should be therapeutically active only against cells that are rapidly cycling. In balance, this appears to be the case, and the side effects of neutropoenia and leukopoenia as well as gastrointestinal-related side effects have been shown to be consistent with the hypothesis that taxol effects are due to mitotic arrest (29, 30) . However, exceptions exist where tumor regression is found despite the lack of actively cycling tumor cells and studies with leukemic lines have indicated that sensitivity to taxol correlates with the induction of MT bundles rather than multipolar aster formation (8, 31) . Therefore, the nature of taxol's therapeutic activity remains to be fully elucidated.
Cell death can be induced by either necrosis or an active process known as apoptosis (32) (33) (34) (35) (36) . The latter appears to be closely linked to the programmed cell death that occurs in development (32) (33) (34) (35) . Typically, high levels of insult induce necrosis, whereas lower levels induce apoptosis (33, 35, 36) . In several cases of cellular differentiation, growth factors serve not only as proliferative and differentiating signals but also serve to rescue precursor proliferating cells from apoptosis (33) (34) (35) . Thus certain cell types, most dramatically cells of the hematopoetic lineages, are particularly poised for apoptosis (low threshold for apoptosis defined in Refs. 33 and 35) . It has now been well established that DNA-damaging cancer therapeutics and y-irradiation exert their cytotoxic effects by inducing the programmed apoptotic pathway following arrest in GI or G2 as opposed to necrosis (36) (37) (38) (39) (40) (41) (42) . The tumor suppressor, p53, has been shown to play a key role in this process. The process of DNA nicking in and of itself induces elevated p53 levels (43, 44) which in turn induce GI arrest by up-regulation of the cdk inhibitor WAF1/Cipl/ p21 (45) (46) (47) (48) to prevent progression past the GI/S checkpoint of cells with damaged DNA. Extensive DNA damage leads to prolonged GI arrest and apoptosis (43) . Similarly, commonly used antineoplastic agents that target DNA, which induce arrest in GI or G2, trigger the same p53 response (42) (43) (44) (49) (50) (51) (52) (53) (54) (55) . Interestingly, many advanced stage tumor types which have poor prognosis with established antineoplastic therapies express a high percentage of p53 mutations (55) (56) (57) (58) (59) . For many tumor types, a late stage event in the progression of the cancer is the clonal expansion of cells expressing mutant p53 alleles (55) (56) (57) (58) (59) . Mutation of the normal cellular p53 gene has been shown to be sufficient to induce cellular immortalization (55, 59, 60) and can enhance tumorigenicity (61) (62) (63) (64) . p53 normally functions as a homo-oligomer; hence, a single mutant p53 allele can lead to a dominant negative phenotype (63, 65) . The discovery that Li Fraumeni patients, genetically predisposed to an abnormally high incidence of cancer, fail to mount a normal p53-mediated response, together with studies indicating that transgenic mice carrying germ line knock-out of p53 alleles are more prone to develop spontaneous cancers and fail to mount an appropriate apoptotic response to -y-irradiation or DNA-damaging antineoplastic agents, provides strong support for the hypothesis that p53 plays an important role in the apoptotic pathways underlying elimination of aberrant tumor cells (42) (43) (44) 49, 50, (52) (53) (54) (55) 61, 66, 67) . Alternative non-p53-dependent apoptotic pathways also exist. These operate in nornal development; for example apoptosis resulting from growth-factor deprivation appears to occur via a p53-independent pathway (33, 35, 52, 54, 68) . Since taxol induces predominantly arrest in early M rather than G1 or G2 arrest in human cells, it is of interest to know whether the apoptotic pathway triggered by taxol (69-71) is dependent on p53.
Here we describe detailed comparative analyses of taxol effects on several human carcinoma lines as well as a normal human line. Kinetic analysis reveals that the majority of human cells become blocked at the G2/M transition in prophase, with only a small percentage progressing through a protracted aberrant mitosis, manifested by a multimininucleated phenotype, to become arrested in the subsequent G1 stage. The lag between mitotic block and cell death is 20-30 hr, with similar EC50 values for both processes. Gl-arrested multimininucleated cells are also destined to die but with much slower kinetics (several days). We further demonstrate that both forms of taxolinduced cell cycle arrest lead to apoptosis. However, apoptosis triggered by arrest in M is initiated very rapidly, within 30 min of arrest at prophase, and appears to operate by a p53-independent pathway. In contrast, both the G1 arrest and subsequent apoptotic death of cells progressing through an aberrant mitosis are p53 dependent. ± 0.3%. Should taxol immediately effect mitotic block, the rate of accumulation in M for the whole population should reflect these kinetics. Therefore the lag between taxol addition and onset of mitotic block indicated either that a minimum time was required to accumulate sufficient intracellular taxol to reach an adequate MT-taxol equilibrium to induce this effect or that time was required for some downstream effects to be manifested. Short, 1-hr taxol treatments revealed that a similar pattern of lag followed by accumulation in M could be observed for the first [8] [9] [10] [11] [12] [13] [14] [15] hr (depending on taxol concentration) indicating that the lag was due to some downstream effect (data not shown).
MATERIALS AND METHODS

Cells
From 4 hr onwards, progressively more cells became blocked in prophase (i.e., at the G2/M transition), at a rate consistent with the doubling time exhibited by the untreated cells. For Hela cells treated with .100 nM, more than 95% of the cells became blocked in prophase within [15] [16] [17] [18] hr, equivalent to the doubling time of the cells (Figs. 1 and 2E). Cell death commenced [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] hr later, as evidenced by Trypan blue exclusion, with the slope of taxol-induced cytotoxicity ressembling that of mitotic block at taxol concentrations at or above 25 nM ( Fig. 1) . At concentrations around the IC50 and below, this relationship is obscured when the data is expressed on a percentage basis since from 2 to 3 days onwards, the cells that passage through M normally continue to rapidly proliferate (see below). A small percentage of the residual attached cells was seen to be multimininucleated (Fig.  2E ). These cells were observed at taxol concentrations of 10 to 25 nM and amounted to less than 5% of the total cell number. At these concentrations a few mitotic figures were observed that had proceeded past the block at prophase to metaphase, but they displayed grossly misaligned 1, M a.; Table 1 ) and died hr later. The remaining cells that did progress through M (aberrant mitosis in Table 1 represents the sum of M-blocked plus cells that pass through abberant M to become multimininucleated) appeared to become arrested in G1, based on the constant chromatin content contained by these multimininucleated cells immediately following their appearance (i.e., bona fide GI) and at all subsequent time points. This G1 arrest was confirmed by FACS analysis for MCF7 and Hs578T cells (these cell lines exhibited a greater fraction of multimininucleated cells than did HeLa cells) since no progression past the 4N DNA compartment was observed in the adherent multimininucleated cell population (data not shown). These GI-arrested multimininucleated cells died after [3] [4] [5] [6] days.
Anti-tubulin IF revealed that 2-4 hr of exposure to taxol above 10 nM induced abnormal multipolar spindles in the prophase-blocked cells (Fig. 3 C and D) compared with the normal bipolar spindle arrays of untreated cells (Fig. 3B) . In contrast, gross rearrangements of MT arrays in interphase cells required concentrations in the [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] ,uM range (5, 6, 73) . As shown in Table 1 , the EC50 values for taxol-induced cytotoxicity at 72 hr correlated with the EC50 for arrest in early M (7-18.5 nM) and were two orders of magnitude lower than the [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] ,uM concentrations required for gross perturbations of interphase MT arrays (73 in prophase displayed defined chromatin structure ( Fig. 3C ; note that this 3D structure cannot be illustrated well by a single plane of focus, given the tightly compacted nature of the chromatin, but the structure was clearly evident with fine focussing up and down through several optical planes). However, by 24 hr following addition of taxol, the chromatin of many cells began to appear globular and more brightly stained ( Fig. 3 E and corresponding phase image F; note, the exposure times for Panels E and G were reduced compared with Panels A, C, and I). The chromatin became progressively more globular as the cells exhibited extensive membrane blebbing and appeared phase-dense (Fig. 3 G and H) . This highly globular and intensely staining DNA pattern was reminiscent of the late sequence of events seen in etoposide-treated cells used as a positive control for apoptosis. However, etoposide-treated cells become arrested in interphase at G1 and exhibit a well-characterized sequence of apoptotic changes in chromatin morphology, initially developing punctate chromatin staining under the nuclear membrane but becoming progressively more globular and brightly Hoechststained as the nuclear structure breaks down (see Fig. 5 G and H) . Therefore, etoposide-treated cells are not directly comparable to taxol-treated cells arrested in M. We therefore carried out gel electrophoresis with 32P-end labeled DNA extracted from taxol-treated cultures to detect DNA ladders, the commonly used hallmark of apoptosis (33, 34, 36) . We employed end labeling to visualize fragments on a molar basis and increase sensitivity to pinpoint the earliest time apoptosis could be monitored by gross DNA fragmentation. Figure 4 shows the results obtained with HeLa cells although identical results were also obtained with Hs578T and MCF-7 cells (data not 1 23 . Bulk DNA analysis does not reveal whether apoptosis is selectively occuring in those cells that are blocked in M at prophase. To address this issue we performed in situ digitonin-dUTP endlabeling (TUNEL, 72). Since enzyme batches were highly variable in this assay, and the procedure was found to be very sensitive to permeabilization and fixation conditions, we routinely used as a control, normal cells that had been briefly treated for 20 min with 50 kl/ml miccrococcal nuclease after fixation before being processed for TUNEL labeling (Fig. 5 I and J) . Only batches of terminal transferase that gave uniformly bright-staining nuclei after in situ nuclease digestion were used. (It should be noted that poor permeabilization and enzyme penetration resulted in only peripheral labeling around the perimeter of the nucleus, again underscoring the importance of internal controls for this technique). TUNEL labeling revealed that indeed only those taxol-treated cells blocked in prophase stained positively (Fig. 5 D-F) . To ensure that the preferential staining of blocked prophase cells was not simply due to more efficient enzyme penetration in mitotic cells due to dissolution of the nuclear envelope and because the chromatin is condensed, we rigorously analyzed many fields of control cells and found all untreated mitotic cells at all stages of mitosis to be TUNEL negative (Fig. 5 A-C, indicated by m) . Only the occasional dead cell stained positively in untreated populations (Fig. 5 A-C Fig. 11 ). Multimininucleated wt p53 MEFs were never seen in mitosis throughout the detailed observations made during the subsequent 1-to 6-day period. Furthermore, those multimininucleated cells remaining attached at 6 days (Fig.  8D) were a similar size with similar chromatin content to multimininucleated cells fixed after 18 hr of taxol treatment (Fig. 8C) indicating arrest in G1. In contrast, multimininucleated p53 -/ -MEFs continued to enter mitosis but as a result of continued aberrant mitosis and lack of cytokinesis, they become progressively larger in size with a progressively greater complement of mini-nuclei (i.e., greater polyploidy; Fig. 8 E-H confirmed this difference dramatically. As illustrated in Fig. 9 , the multimininuclei in wt p53-expressing MEFs all stain very brightly by TUNEL labeling 3-6 days following taxol-induced G1 arrest ( Fig. 9 A-C represents cells after 6 days taxol treatment). In contrast, the multimininuclei in p53-null MEFs remain negative after 6 days ( Fig. 9 D-F) .
The above results might predict that taxol would only have a cytostatic effect on MEFs lacking p53 protein. However, both wt p53 and p53-/-MEFs showed a similar decline in viable cell numbers at higher taxol concentrations (above 100 nM; Fig. 10 ). Although the majority of taxol-treated cells for both MEF lines succeeded in passaging through an aberrant mitosis, a subset did appear to be completely arrested in prophase at taxol concentrations '.100 nM. These detached but rapidly disappeared. Since the numbers of detached, prophase-blocked cells exactly equaled the subsequent (within 2 hr) drop in cell numbers we concluded they must have been cleared by phagocytotic activity of the adherent interphase fibroblasts. Furthermore, Hoechst staining indicated some vesicular Hoechst staining consistent with an endosomal pattern within the interphase cells at the time points coinciding with the loss of cells. (We observed similar results in Ratl fibroblasts; data not shown.) By comparing the EC50 values for block in M, overall aberrant mitosis and net loss of viable cells with respect to starting numbers, it was immediately apparent that the EC50 for taxol-induced cytotoxicity for both wt p53 and p53-/-MEFs correlate with arrest in early M rather than overall perturbation of mitosis (Table  2 ). Since the appearance of prophase blocked cells is only transient and compounded by the phagocytotic activity of these fibroblasts this correlation is easily missed if detailed scoring is not carried out throughout the critical period of [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] hr following addition of taxol.
As mentioned above, those MEFs blocked directly in prophase detached and became nonadherent. Although detachment and Hoechst staining were consistent with these cells being destined for apoptosis, they were too transitory to obtain clearcut morphological evidence of apoptosis. Therefore, we sought to obtain convincing evidence that taxol-induced, early-prophase blocked cells in both MEF lines had initiated apoptosis using TUNEL staining. Cells were fixed after 8-10 hr of exposure to 1 ,uM taxol, while the cells were still adherent (peak detachment of M-blocked cells usually occurred between 10 and 15 hr) for ease of processing for TUNEL. As shown in Fig. 11 , prophase-blocked cells are seen to be TUNEL positive in both wt p53 (Fig. 11, C and D) and p53-null (Fig. 11 E and F) lines and compare with the negative staining of the untreated mitotic cells (Fig. 11, A and B) . Also note the multimininucleated cell at the bottom of Panels C and D which is TUNEL negative at this time point.
DISCUSSION
The data presented above clearly indicates that taxol-induced cytotoxicity correlates with perturbation of mitosis and cell cycle arrest for both the carcinoma lines and the normal HS578Bst line we studied. Our data supports the proposals first made by Kung et al. (Ref. 20 , see also Refs. 19 and 23) and Jordan et al. (18) that taxolinduced cytotoxicity correlates with selective perturbation of mitosis rather than gross changes in interphase arrays as proposed by Rowinsky et al. (8) based on their studies of taxol effects on leukemic lines. We detected two forms of taxolinduced cell cycle arrest: arrest in prophase at the G2/M transition and, for those cells that succeeded in passing through this block and underwent aberrant mitosis; arrest in the subsequent GI stage. For all the human cell lines that we examined, the major fraction of the population entering M during the time period taxol remained effective became arrested in prophase, with only a minor fraction becoming arrested in G1 as multimininucleated cells. As noted previously by others, we found rodent cells to be more tolerant of mitotic arrest per se than human lines (5, 6, 18, 23) . Rather the majority of the population proceeded through a dysfunctional mitosis to become arrested in G1 as multimininucleated cells (the restitution nuclei described by DeBrabander et al. in their studies on rodent PtK2 cells [5, 6] ). However, this species difference is a relative difference rather than an absolute one since we demonstrate here that rodent cells also displayed taxol-induced arrest in early M but at higher taxol concentrations than the EC50 for aberrant M and subsequent G1 arrest. As we have shown, this can be readily missed due to the transitory nature of the detached prophaseblocked cells due to phagocytosis by the adherent interphase cells. Both forms of cell cycle arrest led to cell death which by all morphological and DNA gel criteria occurred by apoptosis irrespective of the species cell type studied. bDeterminations based on absolute decline in total cell number after 6 days with respect to starting numbers at time of taxol addition. -y-irradiation (45, 47, 54, 62) . The G2 block induced by many DNA-damaging antineoplastic agents entails a similar p53-mediated up-regulation of WAFI/Cipl/p21 (41, 54) . Since taxol exhibits a completely different mechanism of action to the other antineoplastic agents, binding specifically to and thereby stabilizing intracellular MTs (1-4) , which in turn induces predominantly arrest in M (1,3,26) , we examined the role of p53 in taxol-induced apoptosis. For this we chose to compare MEFs expressing wt p53 with MEFs with a null p53 phenotype for an unambiguous answer. As expected, p53 status did not affect the primary consequences of taxol treatment. Taxol induced the same aberrant spindle formation in both wt p53 and p53-null MEFs. This led to a subset (--1/3) of cells exhibiting true arrest in prophase at relatively high taxol concentrations (EC50 -130 nM) and the remainder proceeding through aberrant mitosis to become multimininucleated cells (EC50 -46 nM). However, whereas the wt p53-expressing MEFs became arrested in this first GI, the p53-null MEFs failed to arrest. They continued to progress through several rounds of the cell cycle in the absence of cytokinesis, becoming progressively larger with a progressively larger complement of mininuclei. Detailed morphological studies by Hoechst-chromatin staining of treated cell populations strongly suggested the wt p53-expressing multimininucleated cells became immediately arrested in G1 since the chromatin content remained identical from the time these aberrant cells first appeared (i.e., bona fide G1) to all subsequent time points. This was confirmed by FACS analysis. Studies on similar p53+/+ and p53-/-cell lines by Cross et al. (75) , but using the MT-destabilizing agents nocodazole and colcemid, gave FACS DNA content data that was identical to the data we obtained with taxol-treated MEFs. Both by morphological criteria and by TUNEL labeling it was evident that multimininucleated wt p53-expressing MEFs developed all the hallmarks of apoptotic cell death. In contrast, the multimininucleated p53-null MEFs failed to exhibit signs of apoptotic death throughout the following 7-day period. Despite this, higher taxol concentrations induced a similar decline in total viable cell number in both lines rather than exerting solely a cytostatic effect in the p53 null line as might be predicted from the above observations. Detailed morphological characterization throughout the time course of the first cell cycle (- [15] [16] [17] [18] (67) . Since mutant forms of p53 have been shown to have potential "gain of function" activity (63) (64) , it is clear that p53 protein carrying a point mutation is not synonymous with a null phenotype. Recently, it has been shown that antineoplastic agents may still be effective at inducing up-regulated expression of WAFl/Cipl/p21, the downstream effector of p53-mediated G1 or G2 arrest, in cell lines carrying point mutations in p53 (77) .
The study by Cross et al. (75) , which appeared during the final preparation of this manuscript, investigated the effects of the MT-destabilizing drugs, nocodazole and colcemid, which also perturb mitosis, on p53+/+ and p53-null MEFs. Although the data convincingly showed that wt p53 MEFs became arrested with 4N DNA content, but p53-null MEFs failed to arrest and accumulated progressively increasing amounts of DNA, the authors concluded that this data indicated that p53 was essential for a spindle checkpoint in M. However, the 4N DNA compartment was not subdivided into normal G2, cells in M and multimininucleated cells. Therefore, the data could indicate equally well that only the arrest in GI following aberrant mitosis is compromised by the absence of p53. The detailed microscopic analyses we present here, clearly show that for taxol concentrations -100 nM, nearly all cells remaining after 24 hr are multimininucleated cells, so represent cells that have passaged aberrant mitosis to become aberrant 4N DNA-containing cells in GI. Since MT-destabilizing drugs effect a similar M and GI block to taxol (18) (19) (20) 22) , it is clear the accumulation of cells in the 4N DNA compartment observed by Cross et al. (75) actually represent multimininucleated cells after 24 hr. By accounting for the fate of all the cells, which revealed the loss of M-blocked cells by phagocytosis, and titrating a taxol concentration that can effect a block in M at prophase in these murine cells, the data presented here in this report indicates that in fact the mitotic checkpoint is independent of p53 status. Our preliminary observations indicate that cyclin B levels are higher in taxol-blocked prophase cells than in normal cells in prophase through metaphase (data not shown). Further experimentation is required to determine whether this is indicative of heightened p34cd,2/ cyclin B kinase activity. However, these observations are interesting in light of the following observations: (1) prolonged p34cdc2/cyclin B kinase activity might underly colcemid cytotoxicity (45, 46) ; (2) an increase in p34cdc2/cyclin B kinase activity is observed just prior to cell death after cisplatin-induced G2 block (i.e., downstream from the initial p53-WAFI/Cipl/p21 response effecting the G2 arrest [39, 41] ); (3) initiation of apoptosis involves p34cdc2 kinase activation (78) and up-regulation of cyclin A (79, 80) ; and (4) deletion of the wee' kinase responsible for maintaining the p34cdc2 kinase in a phosphorylated inactive form (81) induces a "mitotic catastrophe" state that bears all the morphological features of taxol-blocked apoptotic cells in prophase (82) . It remains to be shown whether, indeed, arrest in M directly activates a p34cdc2 kinase apoptotic response, in comparison with the p5 3-WAF 1 /Cip I/p2I -dependent response that effects G1 block by inhibition of cyclin/cdk kinase activities well in advance of the active process of apoptosis.
Both p53-dependent and -independent pathways of apoptosis have been shown exist. While the former clearly operate in response to DNA damage resulting from y-irradiation and DNA damaging agents (3 5-43) , apoptotic pathways operating in normal development resulting from growth factor deprivation function through p53-independent pathways (52, 54, 68) . Our data suggest that direct block in prophase also bypasses a p53-WAFI /Cipl /p2l -dependent pathway. This could provide some explanation as to why taxol, uniquely among all the chemotherapeutic agents utilized to date, has shown efficacy against advanced stage, drug refractory leukemia, ovarian, and metastatic breast cancers (9) (10) (11) (12) . A high proportion of many types of advanced solid tumor types express mutant p53 (55) (56) (57) (58) (59) 63, 64) . Thus, the commonly used cancer therapeutic agents that induce DNA damage and thereby directly activate the p53-dependent apoptotic pathway would be predicted to be ineffective against late-stage tumors consisting of clonally expanded, p53 mutantexpressing cells. By inducing a rapidly activating, M-block-dependent apoptotic pathway that is p53-independent (and presumably WAFI/Cipl/p21-independent), taxol may therefore bypass at least this one common pathway of aquired resistance to antineoplastic agents. The MT destabilizing drugs (e.g., vinblastine, vincristine, colchicine, podophyllotoxin) also appear to induce cell cycle arrest specifically in M, but to date their use in the clinic has been restricted by a poor therapeutic index. Although taxol appears to have an improved therapeutic index and to be efficacious for a broader spectrum of cancer types, its use is still limited by its poor solubility and side effect profile. Therefore, the discovery of additional structural classes of antineoplastic agents that exhibit a mechanism of action similar to that of taxol and specifically induce arrest in M-phase (73) , but have the potential for an improved side effect and solubility proffile, might prove highly useful in the fight against cancer.
